Cytori Therapeutics CEO transition likely to be seamless, says Maxim After Cytori announced that Chris Calhoun would retire as CEO effective immediately and be replaced by Dr. Mark Hedrick, Maxim expects the transition to be seamless. The firm explains that it believes that Hedrick, who is currently president of the company, and Calhoun are interchangeable. The firm thinks the company's fundamentals are solid and keeps a Buy rating on the stock.
News For CYTX From The Last 14 Days
Check below for free stories on CYTX the last two weeks.